Literature DB >> 10991635

Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?

N A Terrault1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991635     DOI: 10.1002/hep.510320338

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

1.  Lamivudine treatment for recurrent pancreatitis associated with reactivation of chronic B hepatitis.

Authors:  Chien-Hung Chen; Chi-Sin Changchien; Sheng-Nan Lu; Jing-Houng Wang; Chao-Hung Hung; Chuan-Mo Lee
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

2.  Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral hepatitis B.

Authors:  Sien-Sing Yang; Chao-Tien Hsu; Jui-Ting Hu; Yung-Chih Lai; Chi-Hwa Wu
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 3.  Application of nanotechnologies for improved immune response against infectious diseases in the developing world.

Authors:  Michael Look; Arunima Bandyopadhyay; Jeremy S Blum; Tarek M Fahmy
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

4.  Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B.

Authors:  Zheng-Wen Liu; Qun-Ying Han; Ni Zhang; Wen Kang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

5.  Effects of Zhaoyangwan on chronic hepatitis B and posthepatic cirrhosis.

Authors:  Cui-Ping Zhang; Zi-Bin Tian; Xi-Shuang Liu; Qing-Xi Zhao; Jun Wu; Yong-Xin Liang
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.